Clinical Trials

Showing trials with last updates posted in 2016.

NCT02404051 | UNKNOWN | PHASE3
745 participants

Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2016-06-15
Start Date:
2015-12-31
Completion:
2018-01-31
Conditions
  • Metastatic Breast Cancer
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Locally Advanced Malignant Neoplasm
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page